Senior Director, Product Communications
![]() | |
![]() United States, Massachusetts, Cambridge | |
![]() 675 West Kendall Street (Show on map) | |
![]() | |
This role is considered Hybrid.
Overview Reporting to the Chief Corporate Communications Officer, this role will oversee our product communications function encompassing 4 globally marketed brands and 3 late-stage product candidates. This role's primary responsibility will be to serve as the communications head for our leading TTR franchise encompassing both our marketed products ONPATTRO and AMVUTTRA (80%), while also overseeing communications for the rare and late-stage pipeline portfolio. This role will spearhead the development and execution of clinical data and regulatory milestones; congress and publication communications; scientific platform communications for lay audiences; unbranded awareness campaigns; and executive thought leadership campaigns. The Senior Director will also oversee a team of product communications professionals. A successful candidate will have the proven ability to effectively manage complex projects, work collaboratively with stakeholders and across functions, effectively network across the organization and communicate with senior leaders all within a fast moving environment. Key Responsibilities
Qualifications
About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law. > |